FDA Office of Women's Health February e-Update

February 2014 www.fda.gov/womens Message from the Director As we celebrate National Wear Red Day, I encourage you to look to FDA for educational and scientific resources on women and heart disease. Heart disease remains the leading cause of death for women. FDA is committed to educating consumers on how to safely use the medicines, devices, and foods essential for women's heart health. We are also supporting regulatory research to better understand sex-based differences that impact products used to diagnose and treat heart disease. To learn more about these efforts, check out the resources and activities highlighted in this update.   Marsha Henderson Assistant Commissioner for Women's Health FDA Women's Health Highlights Promote Heart Health for Women February is American Heart Month. Use these FDA resources to help the women in your network learn how to prevent heart disease and manage their heart-related health problems.  Visit our updated Heart Health for Women webpage.  Order a free healthy heart publications package. View a summary of OWH-funded research on heart disease in women. Get Cardiovascular Medicine and Device Information. Like the FDA Wear Red Day Photo. Help Women Keep Track of Their Medicines OWH has partnered with the Script Your Future Campaign to distribute materials patients and caregivers can use to keep track of their medications. The promotion offers free bulk copies of a medicine record keeper, wallet card, and brochure with tips on talking to a pharmacist. Order free medication resources in bulk today Follow FDA on Pinterest FDA is now on Pinterest! Follow our women's health board for tips on safe medication use, pregnancy, cosmetics, food safety and more. Share our pins to spread reliable women's health resources and inspire others to live a happier, healthier life. Extras Updated FDA Requirements for Infant Formula FDA published an interim final rule which sets standards for manufacturers to produce safe infant formula. The rule, in part, will ensure that infant formula contains all federally required nutrients. The interim final rule also establishes current good manufacturing practices specifically designed for infant formula. Companies currently manufacturing infant formula in the United States already voluntarily conduct many of the current good manufacturing practices and quality control procedures included in the interim final rule. Public comments will be accepted for 45 days at: http://www.regulations.gov/  (Docket Number FDA-1995-N-0036). Infant Formula Interim Final Rule and Guidance Documents Consumer Information on Infant Formula   FDA's Youth Tobacco Prevention Campaign FDA launched a new campaign "The Real Cost" to educate at-risk youth about the harmful effects of tobacco use. The campaign targets youth aged 12-17. Use these resources to educate the young women in your networks about the risks associated with smoking. Encourage teens to visit "The Real Cost" website Download "The Real Cost" Campaign Materials Share sample tweets and Facebook posts to promote "The Real Cost" Nomination Portal for Advisory Committees FDA launched an online, interactive system that allows interested individuals to submit nominations for membership to any of the agency's 33 advisory committees. Advisory committees provide the FDA with independent, expert advice on a range of complex scientific, technical, and policy issues. View Current Vacancies on FDA Advisory Committees Submit an Advisory Committee Nomination using the Portal FDA Meetings Cardiovascular and Renal Drugs Advisory Committee - Feb. 12  View the meeting announcement and materials.   Cellular, Tissue, and Gene Therapies Advisory Committee - Feb. 25-26  View the meeting announcement and materials Please share this update with your network, members, constituents, and community FDA Office of Women's Health 10903 New Hampshire Avenue WO32 - Room 2333 Silver Spring, MD 20993*0002

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

---

This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420